Picture of ISR Immune System Regulation Holding AB (publ) logo

ISR ISR Immune System Regulation Holding AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: ISR Immune System Regulation Holding Receives Notice Of Objection From Nasdaq

March 8 (Reuters) - ISR Immune System Regulation Holding
AB (publ)  ISR.ST :
    * HAS RECEIVED NOTICE OF OBJECTION FROM NASDAQ
    * HAS RECEIVED REMARK FROM NASDAQ STOCKHOLM INDICATING THAT
NASDAQ
IS CONSIDERING SUBMITTING CASE TO NASDAQ'S DISCIPLINARY
COMMITTEE WITH REQUEST FOR DELISTING
    * NASDAQ BELIEVES THAT ISR HOLDING HAS VIOLATED PROVISIONS
OF
NASDAQ FIRST NORTH GROWTH MARKET RULEBOOK
    * ISR HOLDING DOES NOT SHARE NASDAQ'S ASSESSMENT, BELIEVES
THAT
DELISTING WOULD BE DETRIMENTAL TO CO
    * RESPONSE PERIOD SET BY NASDAQ RUNS UNTIL MARCH 17, 2023

Source text for Eikon:  ID:nWkr8zn965 
Further company coverage:  ISR.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

Recent news on ISR Immune System Regulation Holding AB (publ)

See all news